MetLife stock trades at USD 97.25 as Q3 estimate emerges

Published on 09/25/2026 at 11:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife stock stood at USD 97.25 on September 24, 2026, while the insurer estimated Q3 variable investment income at USD 600 million. Q2 adjusted EPS rose 20 percent.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund — Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife stock (ISIN US59156R1086) stood at USD 97.25 on the NYSE on September 24, 2026, while a fresh filing put preliminary Q3 variable investment income at least USD 600 million pre-tax. The estimate gives the insurer a concrete earnings marker before its next scheduled results on November 4, 2026.

Q3 income sets a new marker

According to Stock Titan, MetLife reported the preliminary estimate on September 24, 2026, for the quarter ending September 30, 2026. Variable investment income includes private equity, real estate, other funds and prepayment fees, while full-year 2026 guidance stands at USD 1.6 billion pre-tax.

The filing also identifies the figure as preliminary and unaudited, making the Q3 estimate an early operating signal rather than a completed quarterly result. For investors, the comparison is important because one quarter's estimated contribution represents a material part of the annual guidance figure.

Q2 earnings show broad growth

MetLife generated USD 19.15 billion in Q2 2026 revenue and USD 1.09 in diluted GAAP EPS, according to the standardized quarterly financial data. The company also reported USD 779 million in consolidated net income for the period ended June 30, 2026.

In the adjusted view, Yahoo Finance reported Q2 2026 adjusted earnings of USD 1.6 billion, or USD 2.43 adjusted EPS, with adjusted EPS up 20 percent year over year. Adjusted ROE reached 17 percent, at the top of the company's 15 percent to 17 percent annual target range.

Analyst target stays above market

TradingView reported that Piper Sandler upgraded MetLife to Overweight and set a USD 110.00 price target on September 22, 2026. That target is USD 12.75 above the September 24 market price, giving the analyst action a clear valuation reference without changing the company's preliminary status for Q3.

Zacks reported that Group Benefits adjusted earnings rose 25 percent year over year to USD 503 million in Q2 2026. The Group Life mortality ratio was 79 percent, below the company's 2026 target range of 83 percent to 88 percent, although Zacks noted that some underwriting benefits may normalize later in the year.

MetLife stock stays near its yearly high

MetLife stock was trading at USD 97.25 on the NYSE on September 24, 2026 at 4:00 p.m. ET, up USD 0.05, or 0.05 percent, from the prior close. The 52-week range was USD 67.33 to USD 100.93, while market capitalization stood at USD 62.57 billion and trading volume reached 3,422,826 shares.